Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dornase Alpha in COVID-19 Treatment
NCT04432987Phase 2Unknown
- Sponsor
- Acıbadem University
- Start
- May 2020
- Primary completion
- Aug 2020
- Countries
- 1
01
Overview
A Phase 2 trial of dornase alfa in coronavirus disease 2019 (COVID-19), sponsored by Acıbadem University. Status: unknown.
02
Drugs
dornase alfa
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04432987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04432987.